The latest price target for Ultralife (NASDAQ:ULBI) was reported by Benchmark on November 15, 2024. The analyst firm set a price target for $14.00 expecting ULBI to rise to within 12 months (a possible 88.68% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Ultralife (NASDAQ:ULBI) was provided by Benchmark, and Ultralife reiterated their buy rating.

There is no last upgrade for Ultralife

There is no last downgrade for Ultralife.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ultralife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ultralife was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.

While ratings are subjective and will change, the latest Ultralife (ULBI) rating was a reiterated with a price target of $14.00 to $14.00. The current price Ultralife (ULBI) is trading at is $7.42, which is out of the analyst’s predicted range.